Nephrotic syndrome (%) | Nephritic syndrome (%) | AUA (%) | ||||
---|---|---|---|---|---|---|
Period 1 | Period 2 | Period 1 | Period 2 | Period 1 | Period 2 | |
Primary GN | ||||||
MPGN | 43.9 | 31.9 | 22.2 | 27.3 | 8.3 | 27.3 |
MesGN(including IgA) | 13.2a | 10.2 | 27.8 | 13.6 | 83.3d | 45.5 |
FSGS | 13.1 | 14.5 | 5.6d | 27.3 | 0d | 18.2 |
MN | 15.8d | 39.1 | 22.2 | 18.1 | 8.4 | 9 |
MCD | 8.8c | 4.3 | 0 | 0 | 0 | 0 |
CGN | 5.2 | 0 | 22.2 | 13.7 | 0 | 0 |
Total (N) | 114 | 69 | 18 | 22 | 12 | 11 |
Secondary GN | ||||||
Immune-mediated | 41.1 | 41 | 11.1d | 54.4 | 50 | 50 |
Dysgammaglobulinaemia associated GN | 21.6 | 20.5 | 0 | 18.2 | 50d | 0 |
Infectious disease associated GN | 33.3 | 33.4c | 88.9d | 27.3 | 0b | 50 |
Others (metabolic, hereditary, etc.) | 4 | 5.1 | 0 | 0 | 0 | 0 |
Total (N) | 51 | 39 | 91 | 1 | 2 | 2 |